UBS Group »

Psyence Biomedical shares owned by UBS Group

Quarter-by-quarter ownership of Psyence Biomedical (PBM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Psyence Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by UBS Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $184 60 3.07

More positions owned by UBS Group

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for UBS Group

Top funds holding Psyence Biomedical

Parallel Advisors
AdvisorShares Investments
Jane Street
XTX Topco
Citadel Advisors
Stonehage Fleming Financial Services Holdings
UBS Group
Caitlin John

View all funds holding Psyence Biomedical